Screening for Down syndrome during first trimester: A prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A

被引:27
作者
Forest, JC
Masse, J
Moutquin, JM
机构
[1] UNIV LAVAL,FAC MED,DEPT BIOCHEM,QUEBEC CITY,PQ G1K 7P4,CANADA
[2] UNIV LAVAL,FAC MED,DEPT OBSTET & GYNECOL,QUEBEC CITY,PQ G1K 7P4,CANADA
关键词
Down syndrome; free beta human chorionic gonadotropin; pregnancy-associated plasma protein A; first trimester; maternal serum screening; prospective study;
D O I
10.1016/S0009-9120(97)00004-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Early screening for Down syndrome is desirable so that more time is left for intervention in the event of a positive test. In retrospective first trimester studies, maternal serum free p-human chorionic gonadotropin and pregnancy-associated plasma protein A have been reported as useful markers. Our objective was to confirm these results in a prospective study carried on an unselected population. Design and Methods: In a cohort of pregnant women recruited prospectively between 9 and 13 weeks' gestation, we measured maternal free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A in all affected pregnancies and 500 representative unaffected pregnancies. Serum concentrations were transformed to multiples of the median value in normal pregnancies of the same length of gestation, and rates of detection of various combinations of the markers were estimated by multivariate analysis. Results: Down syndrome was observed in 18 fetuses from the 10,160 women recruited. Levels of free beta-human chorionic gonadotropin were elevated in affected pregnancies with an overall median value 1.8 times the median of women with normal pregnancies while pregnancy-associated plasma protein A was significantly diminished (0.51 multiples of the median). At a fixed false-positive risk of 10%, 33% (11-55), 50% (27-73), 44% (11-67), and 67% (45-89) of the affected pregnancies would have been detected (95% CI) with maternal age alone or combined with with free beta-human chorionic gonadotropin, pregnancy-associated plasma protein A or both, respectively. Conclusions: We confirm in a prospective noninterventional study that maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A can be used in the first trimester of pregnancy to screen for Down syndrome with a performance similar to second trimester screening programs.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 25 条
[1]  
BERSINGER NA, 1994, BRIT J OBSTET GYNAEC, V101, P70
[2]   SERUM PAPP-A AND FREE BETA-HCG ARE FIRST-TRIMESTER SCREENING MARKERS FOR DOWN-SYNDROME [J].
BRAMBATI, B ;
TULUI, L ;
BONACCHI, I ;
SHRIMANKER, K ;
SUZUKI, Y ;
GRUDZINSKAS, JG .
PRENATAL DIAGNOSIS, 1994, 14 (11) :1043-1047
[3]   LOW MATERNAL SERUM LEVELS OF PREGNANCY ASSOCIATED PLASMA PROTEIN-A (PAPP-A) IN THE 1ST TRIMESTER IN ASSOCIATION WITH ABNORMAL FETAL KARYOTYPE [J].
BRAMBATI, B ;
MACINTOSH, MCM ;
TEISNER, B ;
MAGUINESS, S ;
SHRIMANKER, K ;
LANZANI, A ;
BONACCHI, I ;
TULUI, L ;
CHARD, T ;
GRUDZINSKAS, JG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (04) :324-326
[4]  
BRIZOT ML, 1994, OBSTET GYNECOL, V84, P918
[5]  
CHENG EY, 1993, OBSTET GYNECOL, V81, P72
[6]   ESTIMATING A WOMANS RISK OF HAVING A PREGNANCY ASSOCIATED WITH DOWNS-SYNDROME USING HER AGE AND SERUM ALPHA-FETOPROTEIN LEVEL [J].
CUCKLE, HS ;
WALD, NJ ;
THOMPSON, SG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1987, 94 (05) :387-402
[7]   SCREENING FOR DOWN-SYNDROME DURING THE FIRST AND 2ND TRIMESTERS - IMPACT OF RISK-ESTIMATION PARAMETERS [J].
FOREST, JC ;
MASSE, J ;
ROUSSEAU, F ;
MOUTQUIN, JM ;
BRIDEAU, NA ;
BELANGER, M .
CLINICAL BIOCHEMISTRY, 1995, 28 (04) :443-449
[8]   2ND-TRIMESTER MATERNAL SERUM SCREENING USING ALPHA-FETOPROTEIN, HUMAN CHORIONIC-GONADOTROPIN, AND UNCONJUGATED ESTRIOL - EXPERIENCE OF A REGIONAL PROGRAM [J].
GOODBURN, SF ;
YATES, JRW ;
RAGGATT, PR ;
CARR, C ;
FERGUSONSMITH, ME ;
KERSHAW, AJ ;
MILTON, PJD ;
FERGUSONSMITH, MA .
PRENATAL DIAGNOSIS, 1994, 14 (05) :391-402
[9]   SERUM PAPP-A MEASUREMENTS IN 1ST-TRIMESTER SCREENING FOR DOWN-SYNDROME [J].
HURLEY, PA ;
WARD, RHT ;
TEISNER, B ;
ILES, RK ;
LUCAS, M ;
GRUDZINSKAS, JG .
PRENATAL DIAGNOSIS, 1993, 13 (10) :903-908
[10]   First-trimester Down Syndrome screening: Free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A [J].
Krantz, DA ;
Larsen, JW ;
Buchanan, PD ;
Macri, JN .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (02) :612-616